Browsing Harvard Law School by Keyword "bioterrorism"
Now showing items 1-4 of 4
-
Bioterrorism and the Food Drug Administration: H.R. 3448, Related Legislation, and the FDA’s Expanding Role in Preventing and Responding to Biological Attack
(2002)This paper examines the potential impact of recent and proposed bioterrorism legislation on the U.S. Food and Drug Administration (FDA). It concludes that at least one such piece of legislation, H.R. 3448, the â&eu ... -
Ciprofloxacin and Compulsory Licensing of Pharmaceutical Patents
(2002)The recent threat of biological terrorism involving the Anthrax virus incited a debate about whether the United States government should use its powers under 28 USC §1498 to take a compulsory license on the ... -
The FDA’s Role in the Development of Bioterrorist Countermeasures
(2004)As the agency that approves drug products used to treat bioterrorist diseases, the FDA plays a significant role in the domestic preparation against a bioterrorist attack. The changes that occurred at the agency in response ... -
The National Strategic Stockpile: Will It Really Protect the Nation against Bioterrorism?
(2006)This paper assesses one of the key components of the nation’s defense against bioterrorism—the National Strategic Stockpile. The Stockpile was created by the Bioterrorism Act of 2002 ...